Industry / Biological Product (except Diagnostic) Manufacturing
Trending Companies
Latest filings
15F-12B
PHXM
PHAXIAM Therapeutics
11 Mar 24
Securities registration termination (foreign)
8:31am
EFFECT
PHXM
PHAXIAM Therapeutics
6 Mar 24
Notice of effectiveness
12:15am
S-8 POS
PHXM
PHAXIAM Therapeutics
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:28pm
S-8 POS
PHXM
PHAXIAM Therapeutics
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:27pm
S-8 POS
PHXM
PHAXIAM Therapeutics
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:25pm
S-8 POS
PHXM
PHAXIAM Therapeutics
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:22pm
S-8 POS
PHXM
PHAXIAM Therapeutics
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:14pm
POS AM
PHXM
PHAXIAM Therapeutics
4 Mar 24
Prospectus update (post-effective amendment)
4:09pm
25
PHXM
PHAXIAM Therapeutics
1 Mar 24
Voluntary exchange delisting
4:04pm
6-K
PHXM
PHAXIAM Therapeutics
21 Feb 24
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
6:05am
Transcripts
PHXM
Earnings call transcript
2022 Q3
22 Nov 22
PHXM
Earnings call transcript
2022 Q2
13 Sep 22
PHXM
Earnings call transcript
2022 Q1
13 May 22
PHXM
Earnings call transcript
2021 Q4
14 Mar 22
PHXM
Earnings call transcript
2021 Q3
16 Nov 21
PHXM
Earnings call transcript
2021 Q2
21 Sep 21
PHXM
Earnings call transcript
2020 Q4
9 Mar 21
PHXM
Earnings call transcript
2020 Q3
8 Nov 20
Patents
Utility
Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
PHXM
4 Oct 22
Utility
Arginine Deiminase Encapsulated Inside Erythrocytes and Their Use In Treating Cancer and ARGINASE-1 Deficiency
PHXM
23 Jun 22
Utility
Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency
PHXM
15 Mar 22
Utility
Method of Treating a Mammal, Including Human, Against Cancer Using Methionine and Asparagine Depletion
PHXM
10 Feb 22
Utility
Synergistic Combinations of Methionine Depletion Agents and Immune Checkpoint Modulators
PHXM
30 Dec 21
Utility
Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
PHXM
12 Oct 21
Utility
METHOD OF INDUCING IMMUNE TOLERANCE BY ADMINISTERING ACTIVE PRINCIPLE-LOADING RBC's
PHXM
2 Sep 21
Utility
Composition and Therapeutic Anti-tumour Vaccine
PHXM
18 Mar 21
Utility
Pharmaceutical Composition Comprising Erythrocytes Encapsulating a Plp-dependent Enzyme And, a Non-phosphate PLP Precursor
PHXM
14 Jan 21
Utility
Composition and therapeutic anti-tumour vaccine
PHXM
21 Sep 20